Your prediction
Matthews International Corp. Stock
A loss of -1.630% shows a downward development for Matthews International Corp..
Pros and Cons of Matthews International Corp. in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Matthews International Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Matthews International Corp. | -1.630% | 2.542% | 3.419% | 18.280% | 7.556% | -41.546% | -16.552% |
| Vuzix Corp. | 0.690% | -0.049% | -20.370% | 15.253% | -32.229% | -57.874% | -83.761% |
| USANA Health Sciences Inc. | -3.080% | 3.279% | 4.420% | -25.000% | 14.545% | -67.966% | -76.667% |
| Pola Orbis Holdings Inc. | -2.070% | 2.899% | 5.970% | -3.401% | 2.158% | -45.802% | -63.959% |
Comments
Matthews International Co. (NASDAQ: MATW) had its price target lowered by analysts at B. Riley from $54.00 to $40.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MATW provided by MarketBeat
Matthews International Co. (NASDAQ: MATW) had its price target lowered by analysts at B. Riley from $61.00 to $59.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MATW provided by MarketBeat
Matthews International Co. (NASDAQ: MATW) had its price target raised by analysts at B. Riley from $50.00 to $64.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MATW provided by MarketBeat
News
Eton Pharmaceuticals Q1 Earnings Call Highlights
Eton Pharmaceuticals (NASDAQ:ETON) raised its 2026 revenue outlook after reporting record first-quarter product sales and highlighting early progress from two recent product launches, DESMODA and
AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot
AptarGroup (NYSE:ATR) used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an update on 2025 performance
Is Yum China a Buy After Investment Firm Matthews Purchased Shares Worth $12.57 Million?
According to its SEC filing dated May 4, 2026, Matthews International Capital Management LLC purchased 242,785 additional shares of Yum China (NYSE:YUMC) in the first quarter.
The estimated value of
